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Abstract
Reactive oxygen species (ROS) played an important role in cancer. Although low levels 
of ROS can be beneficial in normal physiological functions, chronic exposure to ROS is 
associated with increased risk of cancers. Increased ROS levels can also induce apopto-
sis and cell death in various types of cancer. Taken together, the role of ROS in cancer 
prevention, formation and therapy is extremely complex and very challenging to study. 
Although the antioxidant activity of phytochemicals is well recognized and generally 
used to prevent cancer, they can have pro-oxidant and ROS generating activities under 
certain conditions, especially at high doses or in the presence of metal ions. The basal 
redox levels of cancer cells are also different from those of normal cells. Therefore, higher 
levels of free form of metal ions and higher levels of endogenous ROS production in 
cancer cells sensitizes them to phytochemicals mediated pro-oxidant cytotoxicity. In con-
clusion, people tend to intake of antioxidant phytochemicals for the detrimental effects 
of ROS. However, excessive intake of phytochemicals could have cancer development or 
therapeutic potential by generating ROS. In this section, the role of phytochemicals in the 
prevention, development and removal of cancer has been discussed.
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1. Introduction
Cancer is already a major health problem and is the second leading cause of death in the 
world. With a 1% increase every year, when it comes to 2030, there will be 26.4 million new 
cases of cancer and about 17 million cancer deaths per year. For this reason, it is necessary to 
develop effective chemopreventive strategies when human life expectancy and environmental 
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conditions are taken into consideration [1]. In addition to genetic factors such as hereditary 
mutations, hormones and immune conditions, environmental factors such as tobacco, diet, 
radiation and infectious organisms are the major cause of cancer formation. These factors 
modulate important cellular elements, including genes such as proto-oncogenes, tumor sup-
pressor genes and DNA repair genes, through cellular intermediates [2].
Oxidative stress is a key component of environmental toxicity during the cancer process and 
reactive oxygen species (ROS) are generated in response to both endogenous and exogenous 
stimuli [3]. ROS such as superoxide radical (O2−.), hydrogen peroxide (H2O2) singlet oxygen 
(1O2) and hydroxyl radical (HO
.), are well known to be cytotoxic and have been implicated 
in the etiology of a wide array of human diseases, including cancer [4]. Various carcinogens 
show their effect by forming ROS during their metabolism [5]. Oxidative DNA damage can 
cause mutations and can, therefore, play an important role in the initiation and progression 
of carcinogenesis [6]. For this reason, the antioxidant balancing function against elevated ROS 
levels is important for many diseases, including various cancers [7]. Researchers have noticed 
that in recent years, the role of ROS depends on their level. While a moderate amount of ROS 
is required for tumor formation, excess ROS serves to kill tumor cells [8].
The relationship between dietary antioxidants and non-communicable diseases (cancer, cardio-
vascular diseases, and cataracts) is largely based on epidemiological studies. These studies have 
shown that there is potential for cancer prevention in plant foods and phytochemicals. Hence, 
in recent years, studies on phytochemicals promoting healthy and disease-preventing potential 
have increased [9]. The interest in plants and phytochemicals in recent years has increased not 
only for cancer but also for the prevention of chronic diseases such as cardiovascular diseases. 
The vast majority of the studies are investigations of the antioxidant properties of phytochemi-
cals [10]. However, some of these phytochemicals act as antioxidants, as well as act as pro-
oxidants and ROS-producing agents that cause oxidative stress in high doses or metal ions, 
especially in the presence of iron and copper [11–13]. In this regard, polyphenols known as 
antioxidants such as quercetin, epicatechins, and epigallocatechin-3-gallate (EGCG) and gallic 
acid have also been shown to produce ROS by pro-oxidant activity in cell models [14–16].
While lower levels of ROS are required for signal transduction and cell proliferation, moder-
ate exposure to chronic ROS has been shown to degrade the antioxidant defense system in 
favor of oxidants, leading to oxidative modification of DNA bases and carcinogenesis [17]. It 
has been commonly accepted that oxidative damage by DNA is one of the most important 
causes of cancer [18]. For example, green tea is advised as a healthy drink due to possessing 
of chemicals which inhibit cancer development [19]. However, when it is consumed very fre-
quently (>1 l/d), it has been associated with increased incidence of esophageal cancer in some 
countries such as northern Iran or India, even though this has been proposed to be due to con-
sumption of hot tea [20, 21]. It has been shown that green tea can produce H2O2 in the mouth 
cavity [22]. It has also been shown that people who took 20 mg/kg β-carotene or 30 mg/day 
β-carotene and 25,000 IU retinyl palmitate supplementation alone developed the incidence of 
lung cancer in smokers [23, 24].
Various methods are used in cancer treatment including chemotherapy, radiotherapy and/or 
surgery, and chemotherapy is one of the basic modalities in the treatment of cancer patients [25]. 
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Most of the chemotherapeutic and radio therapeutic agents kill cancer cells by increasing 
ROS [3], and induce either necrosis or apoptosis of tumor cells [26, 27]. However, they have a 
number of side-effects that can limit their efficacy [28, 29]. Many of the anticancer agents are 
also carcinogenic themselves and the patients may suffer secondary cancers following pri-
mary remission from the initial tumor [30]. For this reason, studies focused on plant-derived 
compounds or their active ingredients with low toxicity and high selectivity for killing cancer 
cells kill plant-derived compounds or cancer cells. In the United States, about 50–60% of can-
cer patients are treated with chemotherapy and/or radiation therapy concurrently or alone 
with phototherapeutic agents that have been confirmed for their anticancer activities [31]. 
There are sufficient evidences to support phytochemical-mediated production of ROS [3], a 
pro-oxidant action that is responsible for their ability to induce apoptosis in cancer cells [32, 
33]. It has been demonstrated that curcumin and ascorbic acid have cytotoxic, genotoxic and 
apoptotic effects on various cancer cells by preclinical and clinical studies [34, 35].
In this chapter, we have tried to explain how phytochemicals derived from plants behave like 
double-edged swords acting as antioxidants or prooxidants according to their dose and envi-
ronment and how they play a role in cancer prevention, formation and treatment.
2. Role of reactive oxygen species in cancer
2.1. Molecular basis of reactive oxygen species
Comprehensively, ROS can be divided into free radicals and non-radical molecules. Although 
free radicals contain one or more unpaired electrons in the outer orbitals of the molecules, 
non-radical ROS do not contain mismatched electrons, but they are chemically active and 
readily convert to free radicals. Superoxide, H2O2 and hydroxyl radicals are the most common 
ROS and studied in cancer. ROS sources are both exogenous and endogenous [36].
Sources of exogenous ROS are food, tobacco, smoke, drugs, xenobiotic, radiation, and other 
mediators. Ionized radiation causes ROS production through interaction with water. Upon 
interaction, an electron is lost and, in turn, a hydroxyl radical (HO.), hydrogen peroxide (H2O2), a 
superoxide radical (O2
−.) and eventually oxygen (O2) [37]. ROS are also produced endogenously in the cell through multiple mechanisms, including mitochondria, peroxisomes, endoplasmic 
reticulum and NADPH oxidase (NOX) complex in cell membranes [38, 39]. Mitochondria 
contain the electron transport chain that transfers electrons from succinate to NADPH during 
respiratory ATP synthesis. During ATP synthesis, the leakage of electrons from the electron 
transport chain causes the molecular oxygen to be reduced to the superoxide [40]. The super-
oxide produced from the mitochondria passes from the mitochondrium to the cytoplasm, exit-
ing through the pores in the outer mitochondrial membrane [41]. Superoxide is converted into 
H2O2 both in mitochondrial matrix (Mn-SOD) and cytosol (with Cu-ZnSOD) [41]. Peroxisomes 
are also crucially important organelles as mitochondria for the production of superoxide and 
H2O2 with the action of various enzymes such as catalase and xanthine oxidase [42]. H2O2 is 
then converted into water by catalase or it can be converted to highly reactive hydroxyl radicals 
in the presence of transition metals [43]. Superoxide is also able to react with reactive nitric 
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oxide (NO) forming peroxynitrite (ONOO–) [44]. Another source of ROS is NOX localized in 
various parts of cellular membranes [45].ROS are also produced during the process of protein 
folding and disulfide bond formation in the endoplasmic reticulum. Glycoprotein endoplasmic 
reticulum oxidoreductin 1, protein disulfide isomerase and NOX4 are the main sources of ROS 
in the endoplasmic reticulum [46]. Under normal physiological conditions, the cells try to sta-
bilize by eliminating the ROS production with the cleaning system [47]. Detoxification of ROS 
is facilitated by non-enzymatic molecules (e.g., Glutathione, flavonoids and vitamins A, C and 
E) or antioxidant enzymes that metabolize different ROS products.
SOD is a metalloenzyme that catalyzes the conversion of superoxide anion to H2O2. SOD uses 
metal ions such as copper (Cu+2), zinc (Zn+2), manganese (Mn+2) or iron (Fe+2) as cofactors. 
“Different SOD enzymes are found in different compartments of the cell and are highly specific 
in regulating bound biologically bound processes” [48]. Catalase is an enzyme that facilitates 
the decomposition of hydrogen peroxide into water and the free oxygen molecule. The major 
localization of catalase in most eukaryotes is cytosol and peroxisomes [49]. Peroxiredoxins are 
thioredoxin peroxidases, which catalyze the reduction of hydrogen peroxide, organic hydro-
peroxides and peroxynitrite [50]. Glutathione has a significant role in cellular signaling and 
antioxidant defense system. It reacts directly with ROS and reactive nitrogen species (RNS) 
and is responsible for the detoxification of free radicals, membrane protection, metabolic reg-
ulation, modulation and signal transduction. The glutathione system involves reduced (GSH) 
and oxidized (GSSG) forms of glutathione. The enzymes required for the system includes 
glutathione reductase (GR), glutathione peroxidase (GPX), glutathione S-transferase (GST) 
[51]. Glutathione protects the cells against oxidative stress by reducing the disulfide bonds of 
cytoplasmic proteins to the cysteines. It is mostly synthesized in the cytosol of the cells and 
prevalent in most of the cells. It is then oxidized to glutathione disulfide. However, the oxi-
dized form, GSSG, is predominant in endoplasmic reticulum. Glutathione peroxidase (GPx) 
is an antioxidant enzyme that effectively reduces H2O2 and lipid peroxides to water and lipid 
alcohols [52]. Glutathione reductase converts GSSG to GSH [53]. Under physiological con-
ditions, almost all of the glutathione are in reduced form because of a constitutive activity 
of glutathione reductase in cells, and the glutathione S-transferases (GSTs) are detoxifying 
enzymes that catalyze the ligation of various exogenous and endogenous electrophilic com-
pounds [54]. GSTs are overexpressed in a variety of tumors to regulate MAPK pathways and 
also play a role in the development of resistance to chemotherapeutics [55].
Normally, the human body naturally tries to compensate by producing endogenous or 
exogenously produced antioxidants against endogenously produced or exogenously taken 
oxidants. Endogenous and exogenous antioxidants act as “free radical scavengers” by pre-
venting and repairing damages caused by ROS [7]. However, under oxidative stress condi-
tions, excessive ROS can damage cellular proteins, lipids and DNA and cause deadly lesions 
in the cells, which contribute to many human diseases, including cancer [56].
2.2. Role of reactive oxygen species in tumor formation
Cancer is a major health problem in almost all parts of the world. It could be resulted 
from both internal and environmental factors. These factors such as inherited mutations, 
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inefficient immune system, smoking, bad diet,, infectious organisms, etc., are able to modulate 
our genes, especially tumor suppressor genes and DNA repair genes [8]. Cellular intermedi-
ates, along with unstable structures, affect cellular signaling pathways through transcription 
factors. These are nuclear factor-kappa B (NF-κB), signal transduction and transcription acti-
vator (STAT)-3, hypoxia inducible factor (HIF)-1α, kinases, various growth factors, cytokines 
and other proteins [56]. Extensive research showed that ROS has crucially important roles 
in modulating genes. Although low levels of ROS can be beneficial to cell, however, exces-
sive accumulation of ROS could modify cell signaling pathways through the transcription 
factors [57]. Although ROS is balanced via endogenous antioxidant defense system, some-
times exogenous antioxidant needs to be supplied to counterbalance ROS-mediated injury. 
However, when oxidative status arises due to inefficient antioxidant system, chronic or 
cumulative oxidative stress eventually causes deleterious modifications in macromolecules 
such as protein, lipid and DNA [3]. ROS can also react with other cellular components such 
as phospholipids and proteins and result in the generation of secondary reactive intermedi-
ates and causes irreversible DNA bases by forming DNA adducts [58]. Formation of DNA 
adducts is the main step of carcinogenic process because, if such adducts cannot be repaired, 
they may lead to DNA damage and eventually to mutations [59]. Oxidative lesions play 
an important role in the etiology of cancer and (8-oxo-dG) lesions can be used as a critical 
biomarker for oxidative DNA damage [60, 61]. ROS can cause 8-OHdG in DNA and cause 
GC → TA transversions [62]. Therefore, 8-OHdG is widely used as biological markers of 
oxidative stress in studies of antioxidants and diseases associated with ROS [63]. Excess ROS 
levels cause DNA mutations such as GC → TA transversion mutations [64], single strand 
breaks and instability [65]. In human tumors, transversion from G to T is the most common 
mutation of the p53 repressor gene [66]. Excessive ROS levels can also increase carcinogen-
esis by inducing and sustaining oncogenic phenotypes of cancer cells [67, 68]. ROS are asso-
ciated with three stages of carcinogenesis, initiation, promotion and progression. In cancer 
formation, ROS contributes to the initiation of nuclear or mitochondrial DNA mutations, 
including point mutations, deletions, chromosomal translocations, and others [69, 70]. The 
initiation stage transforms normal cells into cancer cells. Following the initiation stage, the 
initiated cells are expanded into colonies in the promotion stage, accompanied by cell prolif-
eration and/or inhibition of apoptosis in this stage [7]. ROS promote the expansion of malig-
nant cells by regulating cell proliferation/apoptosis-related genes and transcription factors 
such as nuclear factor-kappa B (NF-κB), activator protein-1 (AP-1), nuclear factor erythroid 
2-related factor 2 (Nrf2), and hypoxia-inducible factor (HIF) [67, 71, 72]. Compared to nor-
mal cells, ROS levels have increased as a consequence of their metabolism in cancer cells, 
and they have a modified redox status to preserve malignant phenotypes [73].
Compared to normal cells, cancer cells are loaded with more ROS. Therefore, they are more 
vulnerable to further ROS attack produced by exogenous ROS-generating factors (prooxi-
dants) [74]. The role of ROS in cancer cells is described as “live by the sword, die by the sword” 
by Schumacher [75] or “a breath of life and death” by Fruehauf and Meyskens [76]. Therefore, 
prooxidant strategy should well be exploited to develop anticancer agents [77]. Although this 
strategy has not commonly been followed in conventional medicinal chemistry and is opposite 
to antioxidant therapy, however, it has promising sites that several ROS producing natural 
Role of Antioxidant Phytochemicals in Prevention, Formation and Treatment of Cancer
http://dx.doi.org/10.5772/intechopen.72217
25
compounds such as phenethyl isothiocyanate [78], piperlongumine [79], curcumin [80] and 
parthenolide [81] are able to kill cancer cells efficiently. Recognizing the importance of ROS in 
cancer therapy, Jim Watson wrote: “The vast majority of all agents used kill ROS, directly or 
indirectly, cancer cells and produce ROS that inhibits important steps in the cell cycle” [74].
3. Phytochemicals
3.1. Phytochemicals and their presence in foods
Phototherapy is the use of plant-based materials to prevent and treat diseases or to promote 
healthy life [82]. The word “phyto” comes from the Greek word for plant meaning, so phyto-
chemicals mean plant chemicals. Phytochemicals are the bioactive non-nutrient plant chemi-
cals found in fruits, vegetables, grains and other plant foods that have health-related effects. 
Vegetables and fruits consumed fresh or processed are the most important sources of phy-
tochemicals necessary for human nutrition. Up to now, about 200,000 phytochemicals have 
been identified and 20,000 of them are derived from fruits, vegetables and grains [83].
Phytochemicals can be classified as carotenoids, phenolics, alkaloids, nitrogen-containing 
compounds and organosulphur compounds [84].These compounds are secondary metabolites 
with a variety of identifiable structures and are common features of the benzene ring and one 
or more hydroxyl groups. Generally, they are classified as flavonoids (anthocyanins, flavan-
3-ols, flavonols, proanthocyanidins or flavones, non-hydrolyzable tannins, isoflavones and fla-
vanones) and non-flavonoids (hydroxycinnamic, hydroxybenzoic acid, hydrolyzable tannins, 
benzoic acids and stilbenes) [85]. Phytochemicals are essential for the growth and reproduction 
of plants, and are produced as a response for defending plants against pathogens and stress in 
general [86]. In the last decade, the results of many researches have shown that phytochemicals 
have also a positive effect on human health. In general, phytochemicals, which are secondary 
metabolites found in plant foods such as alkaloids, phenolic compounds (flavonoids, isoflavo-
noids and anthocyanins) and terpenoids, have gained importance due to antioxidant, antivi-
ral, antibacterial and anticancer effects [87]. Preclinical and clinical studies demonstrated that 
especially phenolic compounds have antimicrobial, anti-inflammatory, antioxidant, antiviral, 
anti-allergic, anticancer, anti-ulcer, antidiabetic, anti-plasmodia, antihypertensive and anticon-
vulsant effects [83]. In addition, food scientists and nutritionists think that consuming phyto-
chemicals as part of a normal human diet is important for a healthy lifestyle [88].
3.2. Phytochemicals and its antioxidant/prooxidant action
A number phytochemicals, especially phenols and flavonoids, are found naturally in food and 
can behave like antioxidants [89]. Most plant foods contain phenols and flavonoids. Green 
leafy vegetables, fruits and yellow vegetables are especially rich in carotenoids, flavonoids 
and vitamin C vitamins. Vitamin C and vitamin E prevent the formation of carcinogenic nitro-
samine [90]. Turmeric (Curcuma domestica), widely used in Indian food, contains a curcumin 
active ingredient, which is a strong antioxidant and a yellow coloring feature that can provide 
Reactive Oxygen Species (ROS) in Living Cells26
protection against cancer [91]. There have been several recent epidemiological studies that 
implicate dietary antioxidant phytochemicals such as carotenoids [92], phenolic compounds 
[93] and flavonoids [94] as protective agents against cancer and cardiovascular disease. Many 
studies have been conducted on how phytochemicals such as vitamin C and E, carotenoids, 
flavonoids and phenolic acids show anticarcinogenic effects [95–97].
It is known that the concentration of antioxidant micronutrients such as vitamin C, vitamin 
E and carotenoids changes between high micromolar and low millimolar levels in human 
plasma and organs, while polyphenol concentrations are at high nanomolar to low micromo-
lar levels [14]. However, despite their low levels, polyphenols have been reported to be more 
effective against oxidative stress than vitamin C [14]. In this respect, it has been suggested that 
phenolics are among the most active substances from natural sources, displaying a variety 
of health-promoting properties such as cytoprotective, antibacterial, antiviral, antiaging and 
anti-inflammatory effects [98, 99]. Some phytochemicals such as catechin and quercetin may 
show antioxidant effects not only due to molecular structures, but also by activating signaling 
pathways such as Nrf-2 [100].
Although the antioxidant activity of phytochemicals is well recognized [98, 99, 101], they can 
also display prooxidant activities under certain conditions, such as at high doses or in the 
presence of metal ions [14, 102, 103]. Prooxidant or antioxidant activity has been shown to 
be dependent on the concentrations of phytochemicals and, in this context, studies using cell 
models have emphasized the prooxidative activities of polyphenols known as antioxidants 
such as quercetin, epicatechin and catechins containing epigallocatechin-3-gallate (EGCG) 
[14, 15, 104, 105]. For example, at high doses, quercetin (50 μM) has been shown to enhance 
the production of superoxide radical (O2
−) in isolated mitochondria and cell culture medium 
[104]. In another study, quercetin has been shown to reduce cell survival and viability, thiol 
content, total antioxidant capacity and SOD, CAT and glutathione transferase activity at 
higher concentrations (> 50 μM), while antioxidant activity of quercetin is observed only at 
low doses (0.1–20 μM) [15]. It has also been shown that flavonoids present in high concentra-
tions can produce ROS with autoxidation (e.g., miksetin and quercetin) and redox cycling 
(e.g., quercetin) [106, 107].
In addition to the antioxidant concentration, prooxidant activity has been reported to be 
directly proportional to the total number of hydroxyl groups in a flavonoid molecule, and 
the presence of metal ions plays an important role [108]. Phytochemicals containing mono- 
and dihydroxy-flavonoids showed no significant prooxidant activity, while compounds con-
taining multiple hydroxyl groups, particularly in group B, have been shown to significantly 
increase hydroxyl radical production by the Fenton reaction [109, 110]. Galati et al. [16] found 
that EGCG was isolated in the presence of transition metals and caused oxidative damage 
to cellular DNA. In the presence of metal ions owing to their reducing capacity and forming 
chelates, antioxidants act directly on free radicals (−R.) by a scavenging process characterized 
by the donation of hydrogen atoms (resulting in the formation of –RH) or electrons (resulting 
formation of –R–) [111]. However, strong reducing power of antioxidants may have potential 
to affect metal ions such as Fe+3 and Cu+2, because they increase their ability to form highly 
reactive HO−. radicals, originating from peroxides via Fenton’s reaction [101, 112].
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  Antioxidant  (AH) +  Fe 3+  (or  Cu 2+ )  →  A . +  Fe 2+  (or  Cu + ) +  H + (1)
  H 2   O 2 +  Fe 2+  (or Cu+)  →  HO . +  HO − +  Fe 3+  (or  Cu 2+ ) (2)
  Fe 2+ +  O 2 +  H 2  O →  Fe 3+ +  HO 2 . +  HO − (3)
  Fe 2+ +  HO 2 
. +  H 2  O →  Fe 3+  HO − +  H 2   O 2 (4)
The antioxidant phenolic compounds, when scavenging the free radicals, can form less reac-
tive phenoxyl radicals and are stabilized by delocalization of unpaired electrons around the 
aromatic ring [113]. However, even though these radicals are relatively stable, they may also 
show prooxidant activities [16]. However, it should be emphasized that natural compounds 
may have harmful effects as well as beneficial effects (independent of their anti-oxidative 
properties); for example, inflammation processes, activation of certain cellular pathways such 
as nitrogen and dicarbonyl metabolisms [16, 114]. It has been demonstrated that β-carotene 
at low doses exhibited antioxidant [115] and anti-inflammatory [116] properties in human 
HL-60 cells.  However, at high doses, it exhibited prooxidant activity [115] and pro-inflam-
matory effects [116].
4. Chemopreventive role of phytochemicals in cancer
4.1. The role of phytochemicals in cancer prevention
Epidemiological studies have shown that the consumption of fruits and vegetables regularly 
reduces the risk of developing chronic diseases such as cancer and cardiovascular diseases 
[117]. The data suggest that people fed on an antioxidant-rich diet have a higher risk of 
chronic diseases and mortality than those who consume less fruits and vegetables. In a cohort 
study, Serafini [118] suggest that high intake of antioxidant-rich fresh fruits, root vegetables 
and vegetables is associated with a reduction in mortality and antioxidant-rich nutraceuticals 
have a protective effect on cancer development.
While the biological functions of polyphenols and/or metabolism in the human body are not 
completely known, there is consensus that antioxidant activity of flavonoids may be a combi-
nation of metal chelating and free radical scavenging properties [118]. Therefore, the structure 
of polyphenols enables them having free radical scavenging activity. Degree of methoxylation 
and the number of hydroxyl groups are important factors enabling them to have antioxidant 
properties. As for phenolic acids, inhibition of oxidation is associated with the cleavage of 
alkoxyl and peroxyl radicals, the cleavage of metal ions by the orthodihydroxy phenolic struc-
ture, and the production of α-tocopherol by reduction of tocopheryl radical [119]. Recently, 
we have shown that the naringenin-oxime compound, having one or more hydroxyl groups 
than naringenin, had more antioxidant and anti-genotoxic potentials than the naringenin in 
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the human mononuclear leukocyte cells [120]. Oxidases such as lipoxygenase (LO), myeloper-
oxidase (MPO), NADPH oxidase and xanthine oxidase (XO) are considered to be one of the 
important mechanisms by which phytochemicals inhibits the formation of high amounts of 
ROS [119]. Phytochemicals also inhibit enzymes indirectly involved in the oxidative process, 
such as phospholipase A2 (FLA2), by stimulating known antioxidant enzyme activities such as 
catalase and superoxide dismutase (SOD) [121]. For this reason, flavonoids can be considered 
as phytochemicals that can interfere directly or indirectly with the formation of free radicals 
[122].
4.2. The role of phytochemicals in cancer formation
It appears that antioxidants are found in the body at sufficient concentrations to prevent 
accumulation of prooxidants (oxidative stress state) and that exogenous antioxidants play an 
important role in maintaining healthy biological systems and establishing redox hemostasis 
at physiological (nutritional) doses [123]. However, exogenous antioxidants, particularly phe-
nolic compounds, can participate in redox reactions that can function as antioxidants (elec-
tron donors) or prooxidants (electron acceptors), depending on their environment [14, 103]. 
The antioxidant or prooxidant activity also depends on their concentration [98]. It is now 
assumed that exogenous antioxidants, including polyphenols, act as “double edged swords” 
according to their cellular redox status [123]. Yordi and Pérez [124] recently published a list of 
such compounds and their dietary sources. Some of the most abundant flavonoids and phe-
nolic acids found in plants were reported to act as prooxidants, besides antioxidant activities: 
quercetin, curcumin, mycetin, kaempferol and caffeic, chlorogenic, ferulic acids and pheno-
lic acids were also demonstrated as prooxidants [125–129]. Several studies have shown that 
oxidative stress is either mediated through the formation of ROS or inhibition of antioxidant 
systems from prooxidant agents [130]. For this reason, the type, phylogenetic, and matrix 
of phytochemicals may be determining factors affecting the balance between beneficial or 
deleterious effects of these natural compounds [123]. It is known that the development of 
many chronic diseases may be due to an oxidative stress, which antioxidant/pro-oxidant bal-
ance cannot provide and may lead to a pathological process [131]. The prooxidants catalyze 
the oxidative reactions of biomolecules, which may lead to cellular dysfunction [132]. It was 
demonstrated that increased prooxidant activity had damaged to biomolecules such as DNA, 
proteins and lipids that were able to lead to a variety of diseases such as cancer and cellular 
death [98, 132]. It was firstly demonstrated that resveratrol can induce oxidative DNA dam-
age in the presence of copper ions [133]. Although it is associated with consumption of hot 
tea, it has been shown that too much tea consumption (>1 l/d) is associated with an increase 
in the incidence of esophageal cancer in some countries such as northern Iran or India [20]. At 
the same time, green tea has been shown to produce H2O2 in the mouth cavity [132]. Because of this, taking plants with high dose phytochemicals is not always effective or safe, sometimes 
may have toxic effects.
In the use of phytochemicals, it is necessary to distinguish pharmacological doses from physi-
ological (nutritional) dosages. Clinically, physiological doses are usually used to optimize or 
maintain optimal health. The pharmacological dose generally requires a doctor’s prescription 
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to treat the specific disease, because in the intake of antioxidant micronutrients, pharmaco-
logical doses are not equal to physiological doses and the intake of antioxidant micronutrients 
may be toxic and can generate cancer.
4.3. Role of phytochemicals in cancer therapy
One of the main features of cancer cells is the survival ability. For this reason, the main goal 
of cancer therapy is to kill cancer cells by selecting them without harming normal cells. There 
are various therapeutic methods to treat cancer including chemotherapy, radiotherapy, and/
or surgery. Chemotherapy is one of the basic modalities in the treatment of cancer patients 
[110]. Although chemotherapy is aimed at removing the desired primary target tumor cells, 
normal cells are also affected and produce many side-effects in multiple organ systems [26, 
134, 135]. For this reason, efforts are being made to develop alternative and effective treatment 
methods. The studies have focused on the active components of plants with low toxicity and 
high selectivity for killing cancer cells.
The primary mechanism of many chemotherapeutic drugs against cancer cells is the forma-
tion of ROS or free radicals [26, 27]. Indeed, there is a realistic approach to treatments aimed 
at strikingly increasing intracellular ROS to kill cancer cells by reducing antioxidant capacity 
[136]. This can be achieved by using compounds that inhibit antioxidant systems or by inhib-
iting specific signaling pathways that upregulate antioxidants in cancer cells. The resulting 
increase in ROS can stimulate tumor cell death through harmful functions of ROS, or through 
apoptosis-specific induction of death signaling pathways. Chemotherapeutics that makeup 
ROS include alkylating agents (melfalan, cyclophosphamide), anthracyclines (doxorubicin, 
epirubicin), podophyllin derivatives (etoposide), platinum coordination complexes (cisplatin, 
carboplatin) and camptothecin (topokan, irinotecan) [137]. Because, high ROS levels results in 
acute damage to cellular components such as DNA, proteins and lipids. ROS can attack DNA 
due to its strong reactivity and can cause DNA base oxidation, DNA lesion and damage to the 
DNA helix [138]. One of the first drugs developed based on ROS production characteristics 
was the procarbazine [139]. It hydrolyzes in aqueous solutions and the cytotoxic effects of the 
drug are the result of H2O2 production [140]. Similar to chemotherapy, radiotherapy also kills 
cancer cells by producing ROS [141]. Cancer cells can be killed by three pathways: apoptosis, 
necrosis, and autophagy [142–144]. Apoptosis is a tightly regulated form of cell death and 
can be initiated by death receptors (extrinsic pathways) or mitochondria (internal pathways), 
and both extrinsic and intrinsic pathways of apoptosis are associated with ROS [145]. ROS 
is also required for Fas phosphorylation at the tyrosine residue, a signal for Fas-associated 
death pathway and caspase-8 and for apoptosis induction [146]. Although it is not known 
that ROS induces apoptosis in excessive amounts, high levels may cause necrotic cell death. 
In some cases, ROS can trigger both apoptosis and necrosis in cancer cells. For example, it has 
been determined that low H2O2 concentrations in Jurkat T lymphocytes cause apoptosis by caspase activation in cells, while higher concentrations cause cell death by inducing necrosis 
[147]. Studies have also shown the role of ROS as a signaling molecule in the stimulation of 
autophagic cell death in cancer cells [148]. Besides the ability of cells to kill, ROS is also neces-
sary for the survival of cancer cells. In fact, the ability of cancer cells to differentiate ROS as a 
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survival or apoptotic signal is related to the dose, duration, type and location of ROS produc-
tion. In short, while moderate levels of ROS are required for cancer cells to survive, extreme 
levels kill them [149, 150].
Although phytochemicals of plant origin are known to have preventive effects on cancer and 
they are widely used in developed countries [151], numerous studies have revealed that many 
of these agents can kill cancer cells [56]. Some drugs, nowadays, used in chemotherapy are 
natural plant-derived products such as (e.g., paclitaxel, vincristine, vinblastine, bleomycin, 
mitomycin, doxorubicin, idarubicin, aclarubicin and actinomycin D). Other chemicals such as 
curcumin, epigallocatechin-3-gallate, genistein, resveratrol, camptothecin, perillyl alcohol, lyco-
pene, phenylethyl isothiocyanate, sulforaphane, aplidin, eicosapentaenoic acid, linoleic acid, 
ursodeoxycholic acid, and vitamin C are in the clinical test stage for the treatment of cancer [1].
The potentials of some phytochemicals to treat cancer were evidenced by both in vitro cell 
culture systems and in vivo mice models [152, 153]. However, their therapeutic effect on can-
cer cells has not been elucidated yet. There are several mechanisms offered for the cytotox-
icity of phytochemicals including the inhibition of topoisomerases, kinases and prooxidant 
actions [16]. Although many phytochemicals known as antioxidants can protect the cell from 
the oxidative stress and neutralize the damaging effect of ROS, however, they can, on the 
other hand, be cytotoxic at high concentrations. However, the mechanism of dual protective-
destructive behavior of flavonoids is not exactly known. It is highly possible that the prooxi-
dant effect is responsible for the selective antiproliferative activity of these compounds, and 
ROS are key signaling molecules to modulate cell death [154]. Because, many phytochemical 
agents exhibit prooxidant action, particularly in the presence of transition metal ions such as 
copper [13, 155]. The prooxidant activity of individual dietary polyphenols and their ability 
to induce mitochondrial dysfunction and consequently apoptosis has been suggested a pos-
sible anticancer mechanism [136]. There seems to be enough evidence to support phytochem-
icals-mediated production of ROS, a prooxidant action that is responsible for their ability to 
induce apoptosis in cancer cells. It was observed that the accumulation of H2O2 is crucial for 
paclitaxel-induced cancer cell death both in vitro and in vivo [156, 157]. Being well known 
that H2O2 can induce selective killing of cancer cells, it seems possible that paclitaxel induced 
H2O2 production plays a role in the selective anticancer effects of this natural product [158]. 
Several in vitro and in vivo studies have also shown that phytochemicals such as catechins, 
phisapubesin B, daucosterol and hesperetin can induce apoptosis induction in various can-
cer cells and animal models [33, 159–162]. Recently, we also demonstrated cytotoxic, apop-
totic, ROS generating and DNA damaging effects of naringenin on cancer and normal cells 
in vitro in cell culture medium [163]. In the same line, the apoptosis inducing effect of EGCG 
has been shown to be due to an increase in caspase-3, -9 and -8 [76–79] expression [164]. 
Similarly, the intrinsic pathway (FAS-independent, caspase 8-independent) by down regula-
tion of ellagic acid Bcl-xL and release of cytochrome C, and colon cancer induced apoptosis 
in Caco-2 cells [165]. Interestingly, ellagic acid, quercetin and curcumin were found to induce 
ROS formation, DNA damage and apoptosis synergistically in cancer cell lines [132, 166, 167]. 
Recently, a combination of chemotherapeutic drug imatinib and curcumin has been used in a 
cancer patient and has been shown to increase efficacy in cancer treatment [168]. In addition, 
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pharmacological doses of vitamin C and curcumin have been reported to be used in the treat-
ment of different types of cancer, and successful results have been reported [169–174].
Studies have shown that many phytochemicals show more cytotoxic effects in various cancer 
cells than in normal cells [175–177]. Some studies have shown that polyphenols such as EGCG 
and genistein kill cancer cells more at the same dose with apoptosis than normal cells [178, 
179]. We also showed that an herbal medicine named ankaferd, derived from different plant 
extracts, killed cancer cells more than normal cells at the same doses [180]. However, it is 
not clear how this differential effect occurs. This may be due to the difference in metabolism 
between cancer cells and normal cells. Since the metabolism of cancer cells is higher than nor-
mal cells, endogenous ROS production levels are much higher than normal cells [181]. The use 
of prooxidant phytochemicals emerges as an exciting strategy to target tumor cells selectively, 
due to further increase in ROS levels in cancer cells. Indeed, our findings show that the pro-
duction of ROS in cancer cells to which phytochemicals are applied is significantly higher than 
normal cells and that there is a positive correlation between ROS level and cell death [163, 180]. 
The advantage of such a strategy is that it is not significantly affected by the fact that basal ROS 
levels of normal cells are lower than cancer cells and therefore less dependent on antioxidants.
Although many in vitro cell culture studies have been carried out on the use of phytochemi-
cals in the treatment of cancer, the number of experimental animals and clinical trials in vivo is 
low. An important problem in in vivo studies is that phytochemicals are digestion, absorption 
and bioavailability. Bioavailability is very low due to low absorption rate of many phyto-
chemicals [182]. Therefore, enteral administration is preferred for cancer treatment [168, 171].
5. Conclusion
In conclusion, extensive researches over the past half a century have indicated that oxygen 
ROS play an important role in cancer metabolism. ROS are one of the main components of 
cell signaling pathways and have been shown to take roles in regulating cell transformation, 
survival, proliferation, invasion, angiogenesis, and metastasis [73, 168]. On the other hand, 
ROS can also suppress tumor progression. However, most chemotherapeutic and radiothera-
peutic agents are designated to reduce the impact of ROS by augmenting ROS stress in cancer 
cells [183]. Due to these dual roles of ROS, both prooxidant-based and antioxidant-based anti-
cancer agents have been developed [184]. It is clear that numerous chemotherapeutics medi-
ate their effects by inducing ROS generation. However, unwarranted side effects of synthetic 
anticancer drugs should be minimized in healthy cells. For this reason, researchers continue 
to look at the nature and explore the potential for cancer treatment. A great number of phy-
tochemicals including some of the vitamins, flavonoids, terpenoids, carotenoids, phenolics, 
phytoestrogens, minerals and antioxidants in plant materials are used for chemoprevention 
of cancer. However, various in vitro and in vivo experiments have shown that phytochemicals 
have carcinogenic potential as well as protective and curative effects against cancer. Many 
studies have shown that these three different effects of phytochemicals on cancer are related 
to the molecular structure of phytochemicals, bioavailability, dose and the oxidative status 
of the administered organism. For this reason, the molecular structure, bioavailability and 
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knowledge of the oxidative status of the applied organism are vital to the phytochemical 
agent used in the prevention or treatment of cancer. Otherwise, treatment with phytochemi-
cals may result in an opposite result to the desired effect.
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